Acelyrin
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Acelyrin generated cash of -$169,705,000, which is less than the previous year. Cash used in financing activities reached the amount of $568,436,000 last year. Net change in cash is therefore -$49,013,000.
Cash Flow
| 2021 | -4.97M | -25M | 124.72M |
|---|---|---|---|
| 2022 | -61.52M | -47.87M | 274.26M |
| 2023 | -169.70M | -447.74M | 568.43M |
SLRN Cash Flow Statement (2021 – 2023)
| 2023 | 2022 | 2021 | |
|---|---|---|---|
Cash at beginning of period | 267.11M | 102.24M | 7.50M |
Operating activities | |||
Net income | -381.64M | -64.77M | -41.83M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 115K | 0 | 0 |
Stock-based compensation expense | 47.31M | 4.05M | 233K |
| Deferred income tax benefit | 47.31M | 4.05M | 233K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 |
Accounts payable | 34.44M | 3.77M | 1.11M |
Cash generated by operating activities | -169.70M | -61.52M | -4.97M |
Investing activities | |||
Purchases Of Investments | -956.51M | -175.97M | 0 |
Investments In Property Plant And Equipment | -2.29M | 0 | -25M |
Acquisitions Net | 10.00M | -83K | 0 |
Cash generated by investing activities | -447.74M | -47.87M | -25M |
Financing activities | |||
Common Stock Issued | 574.13M | 263.48M | 0 |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 |
Cash used in financing activities | 568.43M | 274.26M | 124.72M |
Net Change In Cash | -49.01M | 164.86M | 94.74M |
Cash at end of period | 218.09M | 267.11M | 102.24M |
| Data source |